The Philadelphia Personal Injury Law Blog

Meningitis Outbreak: Drug Reportedly Shipped to Pennsylvania

The Center for Disease Control is warning people in several states, including Pennsylvania, to be on the lookout for meningitis symptoms.

The meningitis outbreak has been linked to The New England Compounding Center (NECC) in Framingham, Mass., reports The Boston Globe.

This after a Boston-area pharmacy was under fire for its link to a recent meningitis outbreak.

These drugs were reportedly shipped to many states, including Pennsylvania, according to the CDC. The state with the highest counts of meningitis was Tennessee, as of Monday's CDC release.

As of Thursday October 11, the CDC was reporting a death toll of 14, with a total of 170 people stricken with the illness, reports Reuters. That's over 60 more cases since Monday, when the CDC reported 105 cases, said The Associated Press.

The numbers are rising. Last week, 47 cases of meningitis had been reported, with five fatalities.

With fingers pointing to the New England pharmacy, the company is likely bracing itself for wrongful death lawsuits. These lawsuits would be filed by the surviving family members of the victims. The liability in the lawsuit would stem from a strict product liability theory where the pharmacy would be in hot water for manufacturing and distributing a product with an inherently dangerous defect.

Damages in a wrongful death suit could be huge. And factor in that so many people were afflicted and the NECC could be seeing a class action lawsuit.

The culprit in the outbreak is a drug called methylprednisolone acetate. This is a steroid, typically used for joint disorders, according to WebMD.

Earlier this week, the drug was recalled by the NECC.

Those who were injected with the drug should be on the lookout for symptoms.

These symptoms include fever, headache, nausea, and stiff neck.

Related Resources: